Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 158,295 | 124,827 | 121,547 | 114,138 | 113,053 |
| Income taxes - deferred | 799 | 3,022 | -2,515 | 22,050 | -5,476 |
| Accounts receivable | -69,790 | -29,697 | -58,990 | -24,719 | 78,617 |
| Accounts payable and accrued liabilities | 108,075 | 126,200 | -101,278 | 105,151 | -5,073 |
| Other Working Capital | 140,420 | 2,503 | -245,864 | 25,639 | 105,989 |
| Other Operating Activity | 254,426 | 103,142 | 368,748 | 159,704 | 138,421 |
| Operating Cash Flow | $592,225 | $329,998 | $81,649 | $401,963 | $425,532 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -199,214 | -160,815 | -143,348 | -161,260 | -120,931 |
| Net Acquisitions | -507,385 | -218,202 | -97,996 | -138,651 | -142,554 |
| Investing Cash Flow | $-706,599 | $-379,017 | $-241,344 | $-299,910 | $-263,486 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 84,302 | 81,945 | 56,060 | -19,079 | 6,977 |
| Debt Issued | 697,608 | 378,860 | 197,440 | 69,723 | 93,747 |
| Debt Repayment | -551,604 | -135,555 | -194,489 | -205,657 | -111,012 |
| Common Stock Issued | N/A | N/A | N/A | -588 | N/A |
| Common Stock Repurchased | 0 | N/A | N/A | 8,530 | -196,961 |
| Dividend Paid | -17,516 | N/A | N/A | 5,002 | 8,164 |
| Other Financing Activity | -151,367 | -228,429 | 25,486 | 107,338 | 51,510 |
| Financing Cash Flow | $61,422 | $96,820 | $84,497 | $-34,731 | $-147,575 |
| Exchange Rate Effect | 5,897 | 3,170 | -3,801 | -7,486 | 424 |
| Beginning Cash Position | 472,433 | 417,448 | 496,447 | 446,239 | 450,313 |
| End Cash Position | 463,000 | 472,433 | 417,448 | 494,453 | 446,239 |
| Net Cash Flow | $-52,951 | $47,801 | $-75,198 | $67,321 | $14,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | 592,225 | 329,998 | 81,649 | 401,963 | 425,532 |
| Capital Expenditure | -202,084 | -162,157 | -145,152 | -161,861 | -123,330 |
| Free Cash Flow | 390,142 | 167,841 | -63,503 | 240,102 | 302,202 |